Deep, targeted upcoming-era sequencing has unveiled that subclonal mutations (i.e., These existing in only a portion of tumor cells) may be detected for all driver genes and therefore are connected to swift disorder development and very poor final result.11–13 This is particularly related for TP53 mutations offered the fact that, as stated down b